SKI Market

Indian Indices

Sensex

83,580.40 266.47
( 0.32%)

Global Indices

Nasdaq

50,145.69 1,215.96
(2.49%)

Dow Jones

6,954.50 135.10
(1.98%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,359.93 50.71
(0.49%)

Forex

USD-INR

90.32 -0.07
(-0.08%)

EUR-INR

106.52 -0.28
(-0.26%)

GBP-INR

122.68 -1.05
(-0.85%)

JPY-INR

0.58 0.00
(-0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531752

INE703D01023

1.0977251

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

34.5

62.28

EPS(TTM)

Face Value()

Div & Yield %

0.02

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1648.99	1439.51	1607.79	1638.35	1524.34	1295.30
Excise Duty	251.24	217.78	245.23	244.40	232.40	190.97
Net Sales	1397.75	1221.73	1362.56	1393.95	1291.94	1104.33
Other Income	38.29	40.64	28.91	19.02	10.18	5.90
Stock Adjustments	-6.79	10.26	-34.00	32.89	-13.59	18.13
Total Income	1429.25	1272.63	1357.47	1445.86	1288.53	1128.36
EXPENDITURE :
Raw Materials	981.20	842.17	951.49	781.49	671.52	911.47
Power & Fuel Cost	40.88	40.26	37.65	30.03	27.21	32.90
Employee Cost	59.22	54.74	46.78	72.60	67.97	28.70
Other Manufacturing Expenses	18.17	17.38	17.57	17.39	14.43	10.92
Selling & Administrative Expenses	55.65	52.01	53.26	43.66	39.60	44.37
Miscellaneous Expenses	21.33	13.42	44.83	18.49	11.02	7.76
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1176.45	1019.97	1151.59	963.65	831.76	1036.12
Operating Profit	252.78	252.66	205.88	482.22	456.79	92.24
Interest	0.19	0.20	1.17	0.17	0.63	0.11
Gross Profit	252.59	252.46	204.71	482.05	456.16	92.13
Depreciation	9.00	9.70	9.92	9.96	10.19	9.52
Profit Before Tax	243.59	242.76	194.79	472.09	445.97	82.61
Tax	63.62	62.95	58.51	122.22	111.78	20.51
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.15	0.08	0.35	0.42	0.79	-4.72
Reported Net Profit	179.82	179.73	135.93	349.45	333.41	66.82
Extraordinary Items	0.08	0.04	0.09	0.09	-0.06	0.84
Adjusted Net Profit	179.74	179.69	135.84	349.36	333.47	65.98
Adjustment below Net Profit	-1.19	-1.10	-0.30	-0.13	-0.47	-1.23
P & L Balance brought forward	872.77	1017.65	931.79	632.24	307.59	250.29
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	99.54	323.52	49.77	49.77	8.30	8.30
P & L Balance carried down	951.86	872.77	1017.65	931.79	632.24	307.59
Dividend	74.66	74.66	33.18	33.18	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	400.00	1700.00	300.00	100.00	50.00
Dividend Per Share(Rs)	4.00	4.00	17.00	3.00	1.00	0.50
Earnings Per Share-Unit Curr	7.23	7.22	8.19	21.06	20.10	4.03
Earnings Per Share(Adj)-Unit Curr	7.23	7.22	5.46	14.04	13.40	2.69
Book Value-Unit Curr	40.20	37.02	64.27	59.09	41.04	21.47
Book Value(Adj)-Unit Curr	40.20	37.02	42.84	39.39	27.36	14.31

83,580.40 266.47 ( 0.32%)

50,145.69 1,215.96 (2.49%)

6,954.50 135.10 (1.98%)

54,176.23 358.19 (0.67%)

10,359.93 50.71 (0.49%)

90.32 -0.07 (-0.08%)

106.52 -0.28 (-0.26%)

122.68 -1.05 (-0.85%)

0.58 0.00 (-0.33%)